ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

IOM Panel Considering NCI Approach To Research In Minorities, Underserved

June 19, 1998

NIH News: NTP To test Herbs for Toxicity

August 13, 1999

FDA Names Director Of New Center For Tobacco Products

September 11, 2009

Congress Reaffirms GRH FY 1986 Cuts

July 25, 1986

NCI, GW Scientists Report Advances On AIDS Vaccine

May 30, 1986

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

September 26, 2014